HC Wainwright & Co. Initiates Coverage On Moleculin Biotech With Buy Rating, Announces Price Target of $3
HC Wainwright & Co. Initiates Coverage On Moleculin Biotech With Buy Rating, Announces Price Target of $3
HC Wainwright & Co.以买入评级启动对Moleculin Biotech的报道，宣布目标股价为3美元
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Moleculin Biotech (NASDAQ:MBRX) with a Buy rating and announces Price Target of $3.
HC Wainwright & Co. 分析师弗农·贝纳迪诺以买入评级开始报道Moleculin Biotech（纳斯达克股票代码：MBRX），并宣布目标股价为3美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。